Development
Gilead Sciences, Inc.
GILD
$112.46
-$2.05-1.79%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 23.37% | 76.24% | 32.56% | 23.65% | -26.23% |
| Total Depreciation and Amortization | 28.06% | 20.05% | 12.62% | 5.52% | 2.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.87% | -62.19% | -56.19% | -45.60% | 58.02% |
| Change in Net Operating Assets | -30.63% | -2,389.39% | 47.51% | -332.95% | -460.53% |
| Cash from Operations | -11.75% | -13.45% | -5.82% | -15.43% | -20.31% |
| Capital Expenditure | 19.64% | 21.62% | 14.45% | 10.74% | -25.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 35.89% | 32.78% | -16.06% | -35.65% | -13.45% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -994.92% | -530.23% | -762.26% | 74.86% | 106.10% |
| Cash from Investing | 8.15% | 19.25% | -26.83% | -2.92% | 21.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | 10.00% | 75.00% | 75.00% | 68.42% |
| Issuance of Common Stock | -24.92% | 163.45% | 101.81% | 78.29% | 82.84% |
| Repurchase of Common Stock | 28.37% | -151.45% | -146.28% | -145.16% | -155.68% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.70% | -2.52% | -2.68% | -2.75% | -2.88% |
| Other Financing Activities | -60.69% | -66.46% | -51.61% | -46.94% | -19.31% |
| Cash from Financing | 20.78% | 18.62% | 25.25% | 25.79% | 27.13% |
| Foreign Exchange rate Adjustments | 190.48% | 164.63% | 129.59% | -6.67% | -80.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 809.46% | 198.52% | 726.62% | 177.06% | 111.23% |